Biologic and Biosimilars


Innovative biologics and upcoming introduction & availability of biosililars developing by recent research and evolution. Various draughts and ultimate guidance has disclosed by FDA to serve bio similar sponsors in expansion data to encourage bio similar submission. FDA rules and regulation are implemented for biosimilars


  • Disease modified ant rheumatic drugs
  • Nonbiologic and conventional
  • Vast produced in living being

Related Conference of Biologic and Biosimilars

May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
July 25-26, 2024

34th Annual European Pharma Congress

Frankfurt, Germany
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
November 28-29, 2024

4th International Conference on Pharmaceutical Chemistry

Bali, Indonesia
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE

Biologic and Biosimilars Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in